Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone

Microbes and Infection

Volumn 8, Issue 9-10, 2006, Pages 2509-2516

  Fonseca, Cristina T ^a,b   Pacífico, Lucila G G ^a   Barsante, Michele M ^a   Rassi, Tatiana ^a   Cassali, Geovanni D ^a   Oliveira, Sérgio C ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

DNA vaccine; Schistosoma mansoni; Sm14

Indexed keywords

COMPLEMENTARY DNA; DNA VACCINE; FATTY ACID BINDING PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 4; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE PRODUCTION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; EXPRESSION VECTOR; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; LUNG LAVAGE; LYMPHOCYTE; LYMPHOCYTE FUNCTION; MEASUREMENT; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PLASMID; PRIORITY JOURNAL; PROVOCATION TEST; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SPLEEN CELL; SUPERNATANT; T LYMPHOCYTE; TH1 CELL; TREATMENT RESPONSE; VACCINATION; WORM INFECTION;

ANIMALS; ANTIBODY FORMATION; BRONCHOALVEOLAR LAVAGE; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DNA, COMPLEMENTARY; FATTY ACID TRANSPORT PROTEINS; FATTY ACID-BINDING PROTEINS; FEMALE; HELMINTH PROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON TYPE II; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; MICE; MICE, INBRED C57BL; NITRITES; PLASMIDS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, DNA;

MURINAE; SCHISTOSOMA MANSONI;

EID: 33749487947     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.06.008     Document Type: Article

References (28)

1. Chitsulo L., Engels D., Montresor A., and Savioli L. The global status of schistosomiasis and its control. Acta Trop 77 (2000) 41-51
2. Harder A. Chemotherapeutic approaches to schistosomes: current knowledge and outlook. Parasitol Res. 88 (2002) 395-397
3. Bergquist N.R., Al-Sherbiny M., Barakat R., and Olds R. Blueprint for schistosomiasis vaccine development. Acta Trop. 82 (2002) 183-192
4. Ismail M., Botros S., Metwally A., Willianm S., Farghally A., Tao L.F., Day T.A., and Bennet J.L. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated by Egyptian villagers. Am. J. Trop. Med. Hyg. 60 (1999) 932-935
5. Moser D., Tendler M., Griffiths G., and Klinkert M. A 14 kDa Schistosoma mansoni polypeptide is homologous to a gene family of Fatty acid-binding proteins. J. Biol. Chem. 266 (1991) 8447-8454
6. Fonseca C.T., Brito C.F., Alves J.B., and Oliveira S.C. IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-gamma and TNF-alpha dependent pathway. Vaccine 22 (2004) 503-510
7. Afonso L.C., Scharton T.M., Vieira L.Q., Wysocko M., Trinchieri G., and Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263 (1994) 235-237
8. Wynn T.A., Jankovic D., Hieny S., Cheever A.W., and Sher A. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J. Immunol. 154 (1995) 4701-4709
9. Argiro L., Henri S., Dessein H., Dessein A.J., and Bourgois A. Induction of a protective immunity against Schistosoma mansoni with ovalbumin-coupled Sm37-5 co-adsorbed with granulocyte-macrophage colony stimulating factor (GM-CSF) or IL-12 on alum. Vaccine 17 (1999) 13-18
10. Jankovic D., Wynn T.A., Kullberg M.C., Caspar R., James S., Cheever A.W., and Sher A. Optimal vaccination against Schistosoma mansoni requires the induction of both B cell and IFNγ dependent effector mechanisms. J. Immunol. 162 (1999) 345-351
11. Robinson H.L. Nucleic acid vaccines: an overview. Vaccine 15 (1997) 785-787
12. Siddiqui A.A., Phillips T., Charest H., Podesta R.B., Quinlin M.L., Pinkston J.R., Lloyd J.D., Pompa J., Villalovos R.M., and Paz M. Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation. Vaccine 21 (2003) 2882-2889
13. Cook R.M., Carvalho-Queiroz C., Wilding G., and LoVerde P.T. Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage. Infect. Immun. 72 (2004) 6112-6124
14. Da'dara A.A., Skelly P.J., Wang M.M., and Harn D.A. Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice. Vaccine 20 (2002) 359-369
15. Brito C.F., Fonseca C.T., Goes A.M., Azevedo V., Simpson A.J., and Oliveira S.C. Human IgG1 and IgG3 recognition of Schistosoma mansoni 14 kDa fatty acid-binding recombinant protein. Parasite Immunol. 22 (2000) 41-48
16. Rosinha G.M., Myioshi A., Azevedo V., Splitter G.A., and Oliveira S.C. Molecular and immunological characterization of recombinant Brucella abortus glyceraldehydes-3-phosphate-dehydrogenase, a T and B cell reactive protein that induces partial protection when co-administrated with IL-12-expressing plasmid in a DNA vaccine formulation. J. Med. Microbiol. 51 (2002) 661-671
17. Smythers S.R., and Terry R.J. The infection of laboratory hosts with cercariae of Schistosoma mansoni and recovery of adult worms. Parasitology 55 (1965) 695-700
18. Bottrel R.L., Dutra W.O., Martins F.A., Gontijo B., Carvalho E., Barral-Netto M., Barral A., Almeida R.P., Mayrink W., Locksley R., and Gollob K.L. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infect. Immun. 69 (2001) 3232-3239
19. Dupre L., Kremer L., Wolowczuk I., Riveau G., Capron A., and Locht C. Immunostimulatory effect of IL-18-encoding plasmid in DNA vaccination against murine Schistosoma mansoni infection. Vaccine 19 (2001) 1373-1380
20. Sim J.I., Kim J.J., Arnold R.L., Shroff K.E., McCallus D., Pachuk C., McElhiney S.P., Wolf M.W., Pompa-de Bruin S.J., Higgins T.J., Ciccarelli R.B., and Weiner D.B. IL-12 gene as DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances TH1 type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge. J. Immunol. 162 (1999) 2912-2921
21. Hogg K.G., Kumkate S., and Mountford A.P. IL-10 regulates early IL-12-mediated immune responses induced by radiation-attenuated schistosome vaccine. Int. Immunol. 15 (2003) 1451-1459
22. Zhu Y., Ren J., Da'dara A., Harn D., Xu M., Si J., Yu C., Liang Y., Ye P., Yin X., He W., Xu Y., Cao G., and Hua W. The protective effect of a Schistosoma japonicum Chinese strain 23 kDa plasmid DNA vaccine in pigs is enhanced with IL-12. Vaccine 23 (2004) 78-83
23. Noormohammadi A.H., Hochrein H., Curtis J.M., Baldwin T.M., and Handman E. Paradoxical effects of IL-12 in leishmaniasis in the presence and absence of vaccinating antigen. Vaccine 19 (2001) 4043-4052
24. Bogan C. The multiplex function of nitric oxide in (auto) immunity. J. Exp. Med. 187 (1998) 1361-1365
25. James S.L., Cheever A.W., Caspar P., and Wynn T.A. Inducible nitric oxide synthase-deficient mice develop enhanced type 1 cytokine-associated cellular and humoral immune responses after vaccination with attenuated Schistosoma mansoni cercariae but display partially reduced resistance. Infect. Immun. 66 (1998) 3510-3518
26. Patton E.A., La Flamme A.C., Pedras-Vasoncelos J.A., and Pearce E.J. Central role for interleukin-4 in regulating nitric oxide-mediated inhibition of T-cell proliferation and gamma interferon production in schistosomiasis. Infect. Immun. 70 (2002) 177-184
27. Pedras-Vasconcelos J.A., and Pearce E.J. Type 1 CD8+ T cell responses during infection with the helminth Schistosoma mansoni. J. Immunol. 157 (1996) 3046-3053
28. Wilson R.A., Coulson P.S., Betis C., Dowking M.A., and Smythies L.E. Impaired Immunity and altered pulmonary response in mice with a disrupted interferon-γ receptor gene exposed to the irradiated Schistosoma mansoni vaccine. Immunology 87 (1996) 275-282